Literature DB >> 3874223

Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.

F W Symington, F Levine, M Braun, S L Brown, H A Erlich, B Torok-Storb.   

Abstract

Human erythroid precursors express Ia antigens that have serology, function, molecular nature, and genetic regulation that are largely unknown. To approach these issues, Ia+ and Ia- subclones of the HEL human erythroleukemia cell line (HEL-DR+ and HEL-DR-, respectively) and an autologous B lymphoblastoid line (B line) were isolated. These erythroid and lymphoid lines were compared with respect to their binding of monoclonal HLA-D subregion-specific antibodies, the ability to trigger in vitro alloproliferation, expression of class II molecules, and transcription of class II-related genes. Unlike the DP+/DQ+/DR+ B lines, HEL-DR+ differentially expressed DP and DR, but not DQ specificities. Also unlike the autologous B line, HEL-DR+ appeared to be unable to trigger primary or secondary allogeneic T cell proliferation, despite the presence of responder monocytes in these cultures and irrespective of lymphokine addition. HEL-DR+ expression of bona fide class II molecules similar to B line DR heterodimers was verified by two-dimensional gel electrophoresis of material immunoprecipitated from 125I-labeled cells. Northern blot analysis of cytoplasmic RNA from these lines indicated that differential class II gene transcription could readily explain the distinct, lineage-related Ia phenotypes of HEL-DR+ and B line. In addition, the lack of invariant chain and class II transcripts in HEL-DR- implied that expression of these unlinked genes in HEL cells is co-regulated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874223

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.

Authors:  F Momburg; K Koretz; A Von Herbay; P Möller
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

2.  Mitomycin C directly augments the expression of HLA-DR antigen in a gastric carcinoma cell line.

Authors:  H Inoue; M Adachi; S Arinaga; H Ueo; T Akiyoshi
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

3.  Locus- and allele-specific DNA-protein interactions in the HLA-DQB1 X box.

Authors:  T L Sukiennicki; L M Shewey; G T Nepom
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

4.  Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast.

Authors:  P Möller; T Mattfeldt; C Gross; P Schlosshauer; A Koch; K Koretz; G Moldenhauer; M Kaufmann; H F Otto
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

5.  Non-co-ordinate expression of HLA-DR antigens and invariant chain.

Authors:  F Momburg; P Möller
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

6.  Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.

Authors:  T Degener; F Momburg; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

7.  An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP.

Authors:  S J Ono; V Bazil; M Sugawara; J L Strominger
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

8.  Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.

Authors:  I Hauber; H Gulle; H M Wolf; M Maris; H Eggenbauer; M M Eibl
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.